We are live on ! Find out more
Steve Schonfeld

Steve Schonfeld Schonfeld Strategic Advisors

AUM $27.9B Turnover 53.32%
1-Year Est. Return 51.18%
 

Steve Schonfeld is the founder of Schonfeld Strategic Advisors, a multi-manager investment firm with roots in proprietary trading. Schonfeld allocates capital across quantitative and discretionary strategies with an emphasis on risk controls and diversification of return streams. The firm is a major name in the multi-strategy hedge fund landscape.

This Fund
S&P 500
This Quarter Est. Return
+28.16%
1 Year Est. Return
+51.18%
3 Year Est. Return
+146.2%
5 Year Est. Return
+181.83%
10 Year Est. Return
+1,058.56%
AUM
$27.9B
AUM Growth
+$13.7B
Cap. Flow
+$4.81B
Cap. Flow %
17.26%
Top 10 Hldgs %
28.91%
Holding
3,207
New
1,059
Increased
750
Reduced
650
Closed
651
Avg Time Held Equity + Options
0.7 years
Top 10 Avg Time Held Equity + Options
0.1 years
Top 20 Avg Time Held Equity + Options
0.1 years
Avg Time Held Equity only
0.8 years
Top 10 Avg Time Held Equity only
0.1 years
Top 20 Avg Time Held Equity only
0.3 years

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$185M
2
META icon
Meta Platforms (Facebook)
META
+$131M
3
ARM icon
Arm
ARM
+$91.4M
4
CRH icon
CRH
CRH
+$78.5M
5
U icon
Unity
U
+$69.3M

Sector Composition

Rank Sector Weight
1 Miscellaneous 47.11%
2 Technology 15.09%
3 Industrials 9.5%
4 Financials 7.56%
5 Consumer Discretionary 5.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
CZR icon
2326
CALL
Caesars Entertainment
CZR
$5.98B
$81.5K ﹤0.01%
+2,700
New +$76.1K
2026 Q2
0 quarters
OPRX icon
2327
OptimizeRx
OPRX
$144M
$81.4K ﹤0.01%
14,227
-60,534
-81% -$348K
2025 Q1
5 quarters
AGNT icon
2328
AGNT Inc
AGNT
$466M
$80.7K ﹤0.01%
+14,924
New +$82.3K
2026 Q2
0 quarters
AFCG icon
2329
AFC Gamma
AFCG
$74.6M
$80K ﹤0.01%
+25,801
New +$81.1K
2026 Q2
0 quarters
GIXXR icon
2330
GigCapital9 Corp Rights
GIXXR
$79.8K ﹤0.01%
+280,000
New +$81.2K
2026 Q2
0 quarters
RGP icon
2331
Resources Connection
RGP
$92.3M
$79.3K ﹤0.01%
+18,649
New +$78.3K
2026 Q2
0 quarters
NUS icon
2332
Nu Skin
NUS
$197M
$78.9K ﹤0.01%
14,945
-27,129
-64% -$173K
2026 Q1
1 quarter
POWW icon
2333
Outdoor Holding Co
POWW
$266M
$75.3K ﹤0.01%
33,023
+8,354
+34% +$17.2K
2026 Q1
1 quarter
PRME icon
2334
Prime Medicine
PRME
$791M
$74.5K ﹤0.01%
+20,189
New +$67K
2026 Q2
0 quarters
BBCQW
2335
DELISTED
Bleichroeder Acquisition Corp II Warrants
BBCQW
$71.9K ﹤0.01%
33,000
-16,950
-34% -$29.1K
2026 Q1
1 quarter
AVXL icon
2336
Anavex Life Sciences
AVXL
$89.3M
$71.4K ﹤0.01%
+27,577
New +$81.6K
2026 Q2
0 quarters
NSPR icon
2337
InspireMD
NSPR
$29.8M
$69.5K ﹤0.01%
+99,275
New +$105K
2026 Q2
0 quarters
III icon
2338
Information Services Group
III
$296M
$69.1K ﹤0.01%
+16,812
New +$70.3K
2026 Q2
0 quarters
MYGN icon
2339
Myriad Genetics
MYGN
$545M
$68.8K ﹤0.01%
12,046
-88,662
-88% -$402K
2024 Q2
8 quarters
MEVOW icon
2340
M Evo Global Acquisition Corp II Warrants
MEVOW
$3.55M
$67.7K ﹤0.01%
+175,861
New +$66.1K
2026 Q2
0 quarters
SKYA icon
2341
SkyAI Inc
SKYA
$122M
$67.4K ﹤0.01%
60,693
-7,181
-11% -$11.5K
2025 Q3
3 quarters
LUNG icon
2342
Pulmonx
LUNG
$127M
$66.1K ﹤0.01%
50,841
+1,053
+2% +$1.45K
2024 Q3
7 quarters
AEYE icon
2343
AudioEye
AEYE
$169M
$65.8K ﹤0.01%
+11,333
New +$78.8K
2026 Q2
0 quarters
ATIIW icon
2344
DELISTED
Archimedes Tech SPAC Partners II Co Warrant
ATIIW
$65.7K ﹤0.01%
30,000
-52,192
-64% -$92.7K
2025 Q2
4 quarters
CLOV icon
2345
Clover Health Investments
CLOV
$2.59B
$65.5K ﹤0.01%
12,500
-28,240
-69% -$95.9K
2025 Q4
2 quarters
ACDC icon
2346
ProFrac Holding
ACDC
$561M
$64.7K ﹤0.01%
11,134
-1,550
-12% -$10.4K
2026 Q1
1 quarter
BORR icon
2347
Borr Drilling
BORR
$1.05B
$64.6K ﹤0.01%
15,653
-3,288
-17% -$17.7K
2025 Q4
2 quarters
AIRS icon
2348
AirSculpt Technologies
AIRS
$60.7M
$64.6K ﹤0.01%
+14,364
New +$58.2K
2026 Q2
0 quarters
IQ icon
2349
iQIYI
IQ
$803M
$64.1K ﹤0.01%
+61,679
New +$71.7K
2026 Q2
0 quarters
IGACR icon
2350
Invest Green Acquisition Corp Rights
IGACR
$64K ﹤0.01%
320,000
– –
2026 Q1
1 quarter

Similar funds

Steve Schonfeld's Q2 2026 Portfolio in Review

As of Q2 2026, Steve Schonfeld held 3,207 positions worth $27.9B, up 96% from $14.2B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Steve Schonfeld deployed $4.81B of net new capital in Q2 2026, opening 1,059 new positions and adding to 750 existing holdings. Its largest new stake was iShares MSCI Brazil ETF: 9,366,387 shares worth $323M.

By sector, the portfolio is most concentrated in Miscellaneous at 47% of assets, up from 34% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $185M trimmed.

  • Steve Schonfeld's largest Q2 2026 buy was iShares MSCI Brazil ETF: 9,366,387 shares worth $323M.
  • Steve Schonfeld added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $689M increase.
  • Steve Schonfeld's biggest Q2 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $185M.
  • Steve Schonfeld fully exited Marvell Technology in Q2 2026, selling an estimated $60.3M.
  • Steve Schonfeld's ten largest holdings make up 29% of its $27.9B portfolio in Q2 2026.
  • Steve Schonfeld opened 1,059 new positions and closed 651 in Q2 2026.
  • Steve Schonfeld's portfolio value rose 96% quarter-over-quarter to $27.9B.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.